Stockreport

Immunic secures $400M to support late-stage MS trials - ICYMI [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF Immunic Inc (NASDAQ:IMUX) earlier this week outlined how a newly secured up to $400 million private placement is set to support completion of late-stage trials and prep [Read more]